These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2645550

  • 21. Comparison of two treatment schedules for combined timolol and dipivefrin therapy.
    Tsoy EA, Meekins BB, Shields MB.
    Am J Ophthalmol; 1986 Sep 15; 102(3):320-4. PubMed ID: 3529971
    [Abstract] [Full Text] [Related]

  • 22. Timolol and epinephrine in primary open angle glaucoma. Transient additive effect.
    Thomas JV, Epstein DL.
    Arch Ophthalmol; 1981 Jan 15; 99(1):91-5. PubMed ID: 7006581
    [Abstract] [Full Text] [Related]

  • 23. Effect of Topically Applied 0.5% Apraclonidine Versus 0.5% Timolol Maleate on Intraocular Pressure of Healthy Horses.
    Ziadi A, Ozmaie S, Asghari A, Rajaei SM.
    J Equine Vet Sci; 2022 Apr 15; 111():103886. PubMed ID: 35093487
    [Abstract] [Full Text] [Related]

  • 24. Concomitant glaucoma therapy with dipivefrin and timolol maleate.
    Thorson JC.
    Trans Ophthalmol Soc N Z; 1981 Apr 15; 33():24-6. PubMed ID: 7020220
    [No Abstract] [Full Text] [Related]

  • 25. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
    Clark JB, Brooks AM, Harper CA, Mantzioros N, Gillies WE.
    Aust N Z J Ophthalmol; 1989 May 15; 17(2):173-7. PubMed ID: 2569321
    [Abstract] [Full Text] [Related]

  • 26. Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma.
    Gandolfi SA.
    Invest Ophthalmol Vis Sci; 1990 Feb 15; 31(2):354-8. PubMed ID: 2406218
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Comparative study between timolol and d-epinephrine in the treatment of open-angle glaucoma (author's transl)].
    Merkle W.
    Klin Monbl Augenheilkd; 1981 Mar 15; 178(3):203-5. PubMed ID: 7014999
    [Abstract] [Full Text] [Related]

  • 29. Effect of apraclonidine in long-term timolol users.
    Gharagozloo NZ, Brubaker RF.
    Ophthalmology; 1991 Oct 15; 98(10):1543-6. PubMed ID: 1683697
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Drop attack in glaucoma. The Melbourne experience with topical miotics, adrenergic and neuronal blocking drops.
    West RH, Cebon L, Gillies WE.
    Aust J Ophthalmol; 1983 Aug 15; 11(3):149-53. PubMed ID: 6639505
    [Abstract] [Full Text] [Related]

  • 32. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.
    Clin Ther; 2006 Apr 15; 28(4):552-9. PubMed ID: 16750466
    [Abstract] [Full Text] [Related]

  • 33. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S, Mundorf TK, Stewart JA, Stewart WC.
    Clin Ther; 2009 Oct 15; 31(10):2063-71. PubMed ID: 19922877
    [Abstract] [Full Text] [Related]

  • 34. A study of the intraocular pressure lowering effect of timolol and dipivalyl epinephrine.
    Frumar KD, McGuinness R.
    Aust J Ophthalmol; 1982 May 15; 10(2):121-3. PubMed ID: 7049141
    [No Abstract] [Full Text] [Related]

  • 35. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA, Vecchi M.
    Invest Ophthalmol Vis Sci; 1996 Mar 15; 37(4):684-8. PubMed ID: 8595970
    [Abstract] [Full Text] [Related]

  • 36. Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine.
    Coleman AL, Robin AL, Pollack IP, Rudikoff MT, Enger C, Mayer PR.
    Arch Ophthalmol; 1990 Sep 15; 108(9):1264-7. PubMed ID: 2205182
    [Abstract] [Full Text] [Related]

  • 37. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?
    Parrow KA, Hong YJ, Shin DH, Shi DX, McCarty B.
    Ophthalmology; 1989 Sep 15; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114
    [Abstract] [Full Text] [Related]

  • 38. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
    Strahlman ER, Vogel R, Tipping R, Clineschmidt CM.
    Ophthalmology; 1996 Aug 15; 103(8):1283-93. PubMed ID: 8764800
    [Abstract] [Full Text] [Related]

  • 39. Long term effect of apraclonidine.
    Araujo SV, Bond JB, Wilson RP, Moster MR, Schmidt CM, Spaeth GL.
    Br J Ophthalmol; 1995 Dec 15; 79(12):1098-101. PubMed ID: 8562543
    [Abstract] [Full Text] [Related]

  • 40. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
    Heijl A, Strahlman E, Sverrisson T, Brinchman-Hansen O, Puustjärvi T, Tipping R.
    Ophthalmology; 1997 Jan 15; 104(1):137-42. PubMed ID: 9022118
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.